| scholarly article | Q13442814 |
| P50 | author | Tatsuhiro Shibata | Q88155392 |
| Michiie Sakamoto | Q114433538 | ||
| Setsuo Hirohashi | Q116761102 | ||
| P2093 | author name string | Akiko Kokubu | |
| Makoto Chuma | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 178-86 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma | |
| P478 | volume | 38 |
| Q36334877 | A novel splicing mutation in the SLC9A3R1 gene in tumors from ovarian cancer patients |
| Q35913641 | Aberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions |
| Q90573808 | An ensemble of flexible conformations underlies mechanotransduction by the cadherin-catenin adhesion complex |
| Q58572361 | Association of PTEN expression with liver function and inflammatory changes in patients with liver cancer after chemotherapy |
| Q40027003 | Beta-oestradiol rescues DeltaF508CFTR functional expression in human cystic fibrosis airway CFBE41o- cells through the up-regulation of NHERF1. |
| Q38708855 | Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinoma |
| Q24323184 | Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling |
| Q34241905 | Cell cycle dependent association of EBP50 with protein phosphatase 2A in endothelial cells |
| Q43106592 | Clinical significance of EBP50 overexpression assessed by quantum dot analysis in gastric cancer |
| Q38304289 | Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function |
| Q84395876 | DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung |
| Q35795744 | Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 Proteins |
| Q41480514 | Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation |
| Q36519010 | Dysregulation of growth factor signaling in human hepatocellular carcinoma. |
| Q22001537 | EBP50 exerts tumor suppressor activity by promoting cell apoptosis and retarding extracellular signal-regulated kinase activity |
| Q36319689 | EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation |
| Q38966467 | EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway |
| Q36392890 | EBP50 promotes focal adhesion turnover and vascular smooth muscle cells migration |
| Q33962655 | EBP50 regulates the apoptosis of pancreatic cancer cells by decreasing the expression levels of Bcl-2. |
| Q33755113 | Engineering Peptide Inhibitors To Overcome PDZ Binding Promiscuity |
| Q42810817 | Estrogens regulate the expression of NHERF1 in normal colon during the reproductive cycle of Wistar rats |
| Q53284573 | Expression of NHERF1 in colonic tumors induced by 1,2-dimethylhydrazine in rats is independent of plasma ovarian steroids. |
| Q52933083 | Expression of Na+/H+ exchanger regulatory factor 1 in autosomal-dominant polycystic kidney disease |
| Q59360209 | Ezrin-Radixin-Moesin Binding Phosphoprotein 50: A Potential Novel Biomarker in Human Papilloma Virus-Associated Head and Neck Squamous Cell Carcinomas |
| Q28588034 | Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia |
| Q37150777 | Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation |
| Q37405006 | Ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) and nuclear factor-κB (NF-κB): a feed-forward loop for systemic and vascular inflammation. |
| Q53593063 | Fine Needle Aspiration Cytology: A Tool to Study NHERF1 Expression as a Potential Marker of Aggressiveness in Lung Cancer |
| Q33302058 | Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors |
| Q47122868 | Hierarchical clustering analysis identifies metastatic colorectal cancers patients with more aggressive phenotype |
| Q37833524 | Histochemistry and cell biology: the annual review 2010. |
| Q37461483 | Identification of EBP50 as a Specific Biomarker for Carcinogens Via the Analysis of Mouse Lymphoma Cellular Proteome |
| Q33932203 | Immunohistochemical analysis of ezrin-radixin-moesin-binding phosphoprotein 50 in prostatic adenocarcinoma |
| Q37099496 | In MMTV-Her-2/neu transgenic mammary tumors the absence of caveolin-1-/- alters PTEN and NHERF1 but not β-catenin expression. |
| Q39493807 | Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells. |
| Q24297357 | Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation |
| Q30479197 | NHERF links the N-cadherin/catenin complex to the platelet-derived growth factor receptor to modulate the actin cytoskeleton and regulate cell motility |
| Q33420852 | NHERF-1: modulator of glioblastoma cell migration and invasion |
| Q49894086 | NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings |
| Q55315464 | NHERF1 inhibits beta-catenin-mediated proliferation of cervical cancer cells through suppression of alpha-actinin-4 expression. |
| Q37702605 | NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway |
| Q42371576 | NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients. |
| Q37246058 | NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia |
| Q36288731 | NHERF1/EBP50 controls lactation by establishing basal membrane polarity complexes with prolactin receptor |
| Q24298305 | NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane |
| Q24294023 | NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands |
| Q34096013 | NHERF1/EBP50 in Breast Cancer: Clinical Perspectives |
| Q34411711 | NHERF1/EBP50 is a new marker in colorectal cancer |
| Q30625458 | NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma |
| Q39459665 | Na(+)/H(+) Exchanger Regulatory Factor 1 (NHERF1) Is Required for the Estradiol-Dependent Increase of Phosphatase and Tensin Homolog (PTEN) Protein Expression |
| Q54112426 | Na+/H+ exchanger regulatory factor 1 overexpression suppresses the malignant phenotype of MIAPaCa-2 pancreatic adenocarcinoma cells by downregulating Akt phosphorylation |
| Q36536571 | Na/H exchange regulatory factor 1, a novel AKT-associating protein, regulates extracellular signal-regulated kinase signaling through a B-Raf-mediated pathway. |
| Q37357067 | Nuclear NHERF1 expression as a prognostic marker in breast cancer. |
| Q83729519 | Overexpression of nuclear NHERF1 in advanced colorectal cancer: association with hypoxic microenvironment and tumor invasive phenotype |
| Q38883994 | PRL-3 Promotes the Malignant Progression of Melanoma via Triggering Dephosphorylation and Cytoplasmic Localization of NHERF1. |
| Q34202681 | PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control |
| Q28115966 | PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma |
| Q24306767 | Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7 |
| Q36066974 | Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma |
| Q43485091 | Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer |
| Q92138246 | Proteomic screen with the proto-oncogene beta-catenin identifies interaction with Golgi coatomer complex I |
| Q36962945 | Ras-activated RSK1 phosphorylates EBP50 to regulate its nuclear localization and promote cell proliferation. |
| Q33597837 | Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells |
| Q26863645 | Regulation of G Protein-Coupled Receptor Function by Na+/H+Exchange Regulatory Factors |
| Q39076960 | Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance. |
| Q37866502 | Roles of the scaffolding proteins NHERF in liver biology |
| Q36808215 | SLC9A3R1 stimulates autophagy via BECN1 stabilization in breast cancer cells |
| Q38840798 | Selective phosphorylation during early macrophage differentiation |
| Q37272524 | Small molecule protein-protein interaction inhibitors as CNS therapeutic agents: current progress and future hurdles. |
| Q91666333 | Specificity of NHERF1 regulation of GPCR signaling and function in human airway smooth muscle |
| Q35633702 | Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1) |
| Q36538416 | Temporal and spatial regulation of ezrin-radixin-moesin-binding phosphoprotein-50-kDa (EBP50) during embryo implantation in mouse uterus |
| Q30479321 | The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. |
| Q37301851 | The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer. |
| Q28576784 | The nuclear receptor hepatocyte nuclear factor 4alpha acts as a morphogen to induce the formation of microvilli |
| Q36214152 | The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy |
| Q37433460 | The protein scaffold NHERF-1 controls the amplitude and duration of localized protein kinase D activity |
| Q35621438 | The scaffolding protein EBP50 promotes vascular smooth muscle cell proliferation and neointima formation by regulating Skp2 and p21(cip1). |
| Q24302333 | The scaffolding protein EBP50 regulates microvillar assembly in a phosphorylation-dependent manner |
| Q39181929 | Tumor suppressor function of ezrin-radixin-moesin-binding phosphoprotein-50 through β-catenin/E-cadher in pathway in human hepatocellular cancer |
| Q42315542 | β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients |
Search more.